News

Researchers Exploring Treatment for Lupus-Based Kidney Disease

By: 

Toby Weber
A healthy human kidney (above) and a kidney from a lupus nephritis patient (below), which shows the disease's classic "flea bitten" look.
A healthy human kidney (above) and a kidney from a lupus nephritis patient (below), which shows the disease's classic "flea bitten" look.

Chandra Mohan has a theory about the development of lupus nephritis, the leading cause of lupus-related deaths. If he’s right, there may already be a treatment.

Lupus is an autoimmune disease that can attack practically any part of the body. In lupus nephritis, it causes severe kidney inflammation, leading to hundreds of deaths and tens of thousands of hospitalizations per year in the United State alone.

In cases of kidney disease caused by something other than lupus, there are high levels of three specific molecules that work together to cause the disease. An enzyme known as kallikrein leads to the production of bradykinin, a peptide that helps regulate blood pressure and inflammation.

At the same time, the kidneys have elevated levels of the two bradykinin receptors, proteins that chemically bond with bradykinin to set certain biological processes in motion.

“If bradykinin binds to receptor two, good things happen in the kidneys,” said Mohan, Hugh Roy and Lillie Cranz Cullen Endowed Professor of biomedical engineering with the University of Houston Cullen College of Engineering. “But if bradykinin binds to receptor one, bad things happen. The kidneys become inflamed and there’s more renal disease.”

While this is the established “pathogenic cascade” of other kidney diseases, recent studies have shown that people with lupus nephritis have elevated levels of these same three molecules – kallikreins, bradykinin and bradykinin receptor one. Thanks to a $200,000 grant from the Alliance for Lupus Research, Mohan will study whether the interaction of these molecules is the cause of lupus nephritis.

Fortunately, he’s got a head start in this process. A drug for other kidney diseases is currently in clinical trials. This drug acts as an inhibitor that attaches to bradykinin receptor one and physically blocks it from bonding with bradykinin. No bond means no kidney inflammation.

Using animal models, Mohan and his research team, including Research Assistant Professor Yong Du, will study how subjects with lupus nephritis respond to the inhibitor drug. If these subjects show significant improvement, he will have established the link between lupus nephritis and the kallikrein/ bradykinin/bradykinin receptor one pathogenic cascade.

More than that, though, Mohan will have shown that the inhibitor is also an excellent candidate for treating lupus nephritis, one that could, hopefully, come to market relatively quickly.

“There’s a high chance this will work,” said Mohan. “The company that developed the drug has already gone through many libraries of molecules and selected this inhibitor and it seems to be working in clinical trails with other renal diseases. The safety of the inhibitor has already been established. So if our experiments go well, the trials can quickly move to human lupus nephritis in just a few years.”

Faculty: 

Department/Academic Programs: 

Tag: 

Related News Stories

23 honored with 2020-21 Faculty and Student Excellence Awards

The W.T. Kittinger Teaching Excellence Award is traditionally the highest teaching award given in the College. It recognizes outstanding teaching and service to students. This year's recipient is Di Yang of Mechanical Engineering.

The Cullen College of Engineering at the University of Houston and Dr. Joseph W. Tedesco, Ph.D., P.E., the Elizabeth D. Rockwell Endowed Chair and Dean, are pleased to share the 2020-21 Faculty and Student Excellence Award winners.

The initial announcement was made during the virtual Spring 2021 State of the College Address on May 4.

21 Cullen College students receive SURF opportunities

A group of 21 students from the Cullen College of Engineering have been selected for the University of Houston's Summer Undergraduate Research Fellowships.

The Cullen College of Engineering is proud to announce that 21 undergraduate students have been selected for the University of Houston's Summer Undergraduate Research Fellowship (SURF), according to the Honors College.

UH, HCC partnering on Engineering Academy at Fraga campus

An exterior shot of the flags flying at the Houston Community College's Fraga Campus. The University of Houston's Cullen College of Engineering and HCC will be partnering to create an Engineering Academy on the campus.

The University of Houston's Cullen College of Engineering and Houston Community College have reached an agreement to offer UH Engineering Academy courses at the HCC Felix Fraga Academic Campus on the east side of Houston on Navigation Boulevard.

Upcoming Events / Seminars